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E-mail address: ljiljana.majnaric@hi.t-com.hr (L. TThe major challenge in inﬂuenza vaccination is to predict vaccine efﬁcacy. The purpose of this study was
to design a model to enable successful prediction of the outcome of inﬂuenza vaccination based on real
historical medical data. A non-linear neural network approach was used, and its performance compared
to logistic regression. The three neural network algorithms were tested: multilayer perceptron, radial
basis and probabilistic in conjunction with parameter optimization and regularization techniques in
order to create an inﬂuenza vaccination model that could be used for prediction purposes in the medical
practice of primary health care physicians, where the vaccine is usually dispensed. The selection of input
variables was based on a model of the vaccine strain which has frequently been changed and on which a
poor inﬂuenza vaccine response is expected. The performance of models was measured by the average hit
rate of negative and positive vaccine outcome. In order to test the generalization ability of the models, a
10-fold cross-validation procedure revealed that the model obtained by multilayer perceptron produced
the highest average hit rate among neural network algorithms, and also outperformed the logistic regres-
sion model with regard to sensitivity and speciﬁcity. Sensitivity analysis was performed on the best
model and the importance of input variables was discussed. Further research should focus on improving
the performance of the model by combining neural networks with other intelligent methods in this ﬁeld.
 2010 Elsevier Inc. All rights reserved.1. Introduction
Prevention and control of inﬂuenza epidemics is a major chal-
lenge for public health care services. The current approach is
annual vaccination with a trivalent inactivated inﬂuenza vaccine
(against the A/H1N1, A/H3N2 and B inﬂuenza virus strains) [1].
Although this approach is generally safe and effective in preventing
inﬂuenza, there is a need for inﬂuenza vaccines with improved efﬁ-
cacy in the elderly [2]. This need is based on the observation that
available vaccines are less effective in the elderly than in the youn-
ger population [2,3]. Factors responsible for these differences have
been identiﬁed and include: older age, previous exposures to inﬂu-
enza viruses, pre-existing antibody titres and chronic aging dis-
eases [4,5].
Several new vaccine preparations and vaccination approaches
are currently being pursued in order to improve the efﬁcacy of
inﬂuenza vaccines in the elderly [6,7]. Decision on the introduction
of new vaccines into national vaccination programs is, however,ll rights reserved.
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rtica-Majnaric).connected with the demand for cost-effectiveness analyses and
development of an inﬂuenza vaccination action plan [8]. The main
challenge is to predict which individual will most likely adequately
respond to conventional inﬂuenza vaccines and which individual
will not.
Experience from clinical medicine suggests the use of a biology
systems approach within the context of artiﬁcial intelligence,
when obtaining models of prediction [9]. This assumption is based
on the observation that chronic aging diseases are characterized by
multiple factors, interacting with each other in a non-linear
manner. This is the reason for the huge variability in disease
expression and severity among individuals [10]. The artiﬁcial
neural networks (ANN) has been shown to be a suitable com-
puter-based method which can incorporate non-linear effects
and interactions between multiple variables in a valid probability
model [11].
Neural networks (NNs) as one of the artiﬁcial intelligence meth-
ods has been successfully used for classiﬁcation, prediction and
association in different ﬁelds, including general purpose, as well
as some speciﬁc ﬁelds, such as diagnosis of disease [12]. Together
with genetic algorithms, clustering algorithms, decision trees and
other methods, NNs are widely used in Data Mining methodology
for revealing hidden non-linear relationships among data [13].
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has remarkable information processing characteristics, pertinent
mainly to non-linearity, high parallelism, fault and noise tolerance,
learning and generalization capabilities [14]. Some of the other
advantages of NNs are the ease of optimization, cost-effectiveness
and ﬂexible non-linear modeling of large datasets, and accuracy for
predictive inference showing that NNs could serve as a valuable
decision support tool in different areas, including medicine [15].
Three NN algorithms were tested in this paper: multilayer percep-
tron (MLP), radial-basis function network (RBFN) and probabilistic
network (PNN). MLP is a general purpose feedforward network,
and one of the most frequently used NN algorithms. In order to
optimize the error function it uses the classical backpropagation
algorithm based on deterministic gradient descent algorithm orig-
inally developed by Paul Werbos in 1974, extended by Rumelhart,
Hinton, Williams (in [16]). RBFN is based on a clustering procedure
for computing distances among each input vector and the center,
represented by the radial unit. The ability of RBFN with one hidden
layer to approximate any non-linear function has been demon-
strated by Park and Sandberg (in [17]). The PNN algorithm was
tested due to its fast learning and efﬁciency in classiﬁcation. It is
a stochastic-based NN developed by Specht (in [16]). The architec-
ture of the PNN is based on Bayes’classiﬁer, using the Parzen win-
dow estimator to estimate the probability distributions of the class
samples [18].
Logistic regression (LR) modeling is widely used for analyzing
multivariate data involving dichotomous responses dealt with in
this paper. It provides a powerful technique analogous to multiple
regression and ANOVA for continuous responses. Since the likeli-
hood function of mutually independent variables Y1; . . . ;Yn with
outcomes measured on a binary scale is a member of the exponen-
tial family with ðlogð p11p1Þ; . . . ; logð
pn
1pnÞÞ as a canonical parameter
(pj is a probability that Yj becomes 1), the assumption of the logis-
tic regression model is a linear relationship between a canonical
parameter and the vector of explanatory variables xj (dummy vari-
ables for factor levels and measured values of covariates):
log
pj
1 pj
 
¼ xsj b ð1Þ
This linear relationship between the logarithm of odds and the vec-
tor of explanatory variables results in a non-linear relationship be-
tween the probability of Yj equals 1 and the vector of explanatory
variables:
pj ¼ expðxsj bÞ=ð1þ expðxsj bÞÞ ð2Þ
Detailed description of the logistic regression can be found in
Harrel [19].
Three NN algorithms, as well as logistic regression were used in
order to provide the inﬂuenza vaccination probability model that
could be used for prediction purposes in the practice of primary
health care physicians, where the vaccine is usually dispensed.2. Materials
The study was based on original data collected in primary
health care in Croatia. A total number of 90 patients, out of 150
individuals requiring the inﬂuenza vaccine during 2003/2004, gave
their consent and were enrolled in the study. There were 35 male
and 55 female patients, 50–89 years old (median 69), all suffering
from multiple chronic medical conditions. Study protocol was ap-
proved by the local ethics committee.
The commercially licensed trivalent inactivated split vaccine
was used for the vaccination, manufactured by Solway, the Nether-
lands, containing the following inﬂuenza virus strains: A/H1N1/
New-Caledonia/20/99-like, A/H3H2/Moscow/10/99-like andB/HongKong-330/2001-like. Speciﬁc antibody production was measured
by the Hemagglutination Inhibition (HI) test, a standard microtitre
technique. At least a fourfold increase in antibody titre was used
for expression of the speciﬁc antibody induction. For calculation
of geometric mean titres (GMT), a titre of <1:10 was arbitrarily set
at 5. The inﬂuenza B vaccine strain was also tested on the B/Sicuan
379/99 strain, contained in the vaccine in the recent past, for a het-
erologous reaction [1].
The target attribute in our study was the vaccination reaction to
the inﬂuenza vaccine virus strain B/Hong Kong. The output variable
used in NN models was binary, expressed in the form of two cate-
gories, where 0 value denoted the category of negative vaccine
reaction, or less than the fourfold increase in antibody titre, while
the value of 1 denoted the positive vaccine reaction, or the fourfold
and more increase in antibody titre.
Available input space included a large set of variables, such as:
the physician’s diagnoses of the main groups of chronic diseases,
anthropometric measures, hematological and biochemical labora-
tory tests. Blood tests were chosen on the basis of two criteria:
(a) to determine the main age-related pathogenetic changes and
(b) to be available in a real health care system setting. Based on
these criteria, we performed blood tests to determine: (1) inﬂam-
mation, (2) nutritional status, (3) metabolic status, (4) chronic re-
nal impairment, (5) latent infections, (6) humoral immunity and
(7) the neuroendocrine status. Blood samples were collected from
subjects three times prior to the vaccination and once 4 weeks
after the vaccination (for paired serum measuring). Hematological
analyses were carried out on fresh blood samples, while sera for
biochemical analyses and serological tests were separated by cen-
trifugation and stored at 40 C until assayed.
Due to the large dimension of initial input space, it was neces-
sary to reduce the number of input variables before NN and LR
modeling. Non-linear Data Mining algorithms were used for this
purpose, resulting in a ﬁnal set of 26 input variables [20]. Conse-
quently, the results obtained by NN and LR modeling could be
biased by the choice of the preprocessing method. Future research
should be focused on the use of other preprocessing methods in
modeling, and use of more datasets.
The total 26 input variables used in the NN and LR models can
be divided into three groups: (1) data related to previous exposure
to inﬂuenza viruses (the number of previous vaccinations and pre-
existing antibody titres for all four inﬂuenza virus vaccine strains,
measured in the study), (2) the set of medical data, and (3) age
(implicating age-related changes in the immune system). All avail-
able input variables and their descriptive statistics (mean and stan-
dard deviation for continuous variables, frequencies for categorical
variables) are presented in Table 1.
The whole sample consisted of 60 patients with negative vac-
cine outcome, and 30 patients with positive vaccine outcome.
Many authors, such as Liu and Tourassi, emphasize that model
selection should be performed on the basis of generalization error
[21,22]. Some of the well-known methods for testing the general-
ization ability of models are n-fold cross-validation, jackkniﬁng,
bootstrapping and round robin technique [13,22]. All of them
have the purpose of reducing the small-sample estimation bias
and variance contributions [22,23]. Cross-validation was used in
this paper because it produces no statistical bias of the result
since each tested sample is not a member of the training set.
According to Witten and Frank, extensive tests on numerous
datasets have shown that 10 is a sufﬁcient value for n in the n-
fold cross-validation [13]. Therefore, a 10-fold cross-validation
procedure (or leave k cases out, where k = 1/10 of the total sam-
ple) was performed according to a slightly modiﬁed description of
Masters including the following steps: (1) the in-sample data
were divided into 10 equally-sized independent subsamples, (2)
each NN model estimated 10 times, each time using a different
Table 1
Input variables and their descriptive statistics.
Variable No. Variable code Variable description Descriptive statistics
1 VACC The number of previous vaccinations 0 = 39.79%
0 = vaccinated for the ﬁrst time 1 = 20.43%
previously vaccinated: 1 = once, 2 = two or three times 2 = 13.98%
3 = four or more times 3 = 25.81%
2 H1N1_1 Pre-existing antibody titre on the inﬂuenza virus A/H1N1 strain Mean = 11.08
stdev = 22.38
3 H3N2_1 Pre-existing antibody titre on the inﬂuenza virus A/H3N2 strain Mean = 69.68
stdev = 63.54
4 KONG_1 Pre-existing antibody titre on the inﬂuenza virus B/Hong Kong strain Mean = 43.44
stdev = 99.90
5 SICM_1 Pre-existing antibody titre on the inﬂuenza virus B/Sicuan strain Mean = 30.32
stdev = 44.64
6 GLU Fasting blood glucose Mean = 6.52
stdev = 2.10
7 SKINFOLD Triceps skinfold thickness (indicating malnutrition) Mean = 33.37
stdev = 7.38
8 AGE Age Mean = 67.66
stdev = 7.96
9 PSYCH Neuropsychiatric diseases (anxiety/depression, Parkinson’s disease,
cognitive impairments) (0 = no, 1 = yes)
0 = 40.86%
1 = 59.13%
10 HPA Helicobacter pylori speciﬁc antibodies type IgA (indicating chronic gastritis) Mean = 32.61
stdev = 51.39
11 HPG Helicobacter pylori speciﬁc antibodies type IgG (indicating chronic gastritis) Mean = 66.53
stdev = 63.42
12 EO Eosinophils % in White Blood Cell differential (indicating humoral immunity) Mean = 3.85
stdev = 2.65
13 MO Monocytes % in White Blood Cell differential (indicating immune cell activation) Mean = 8.10
stdev = 2.26
14 LY Lymphocytes % in White Blood Cell differential (indicating lymphopenia) Mean = 35.45
stdev = 8.99
15 MCV Mean Cell Volume (indicating vitamin B12 deﬁciency) Mean = 91.03
stdev = 5.03
16 ALB Serum albumin (indicating inﬂammation/malnutrition) Mean = 46.11
stdev = 3.13
17 CRCLEA Creatinine clearance(indicating chronic renal impairment) Mean = 1.69
stdev = 0.45
18 HOMCYS Amino acid homocysteine (indicating nutritional status/chronic renal impairment) Mean = 12.35
stdev = 3.81
19 BETA Beta-globulins in serum proteins electrophoresis (indicating low-grade chronic inﬂammation) Mean = 8.44
stdev = 0.94
20 GAMA Gamma-globulins in serum proteins electrophoresis (indicating low-grade
chronic inﬂammation/chronic humoral immune reaction)
Mean = 12.47
stdev = 2.29
21 VITB12 Vitamin B12 (indicating vitamin B12 deﬁciency/the nutritional status) Mean = 284.33
stdev = 158.79
22 PRL Hormone prolactin (indicating hyperprolactinemia) Mean = 124.57
stdev = 120.39
23 TSH TSH (thyroid-stimulating hormone) (indicating thyroid gland hormone hypofunction) mean = 2.04
stdev = 2.61
24 FT3 Free triiodothyronine (thyroid gland hormone)(indicating thyroid gland hormone hypofunction) Mean = 5.46
stdev = 0.53
25 FT4 Free thyroxine (thyroid gland hormone) (indicating thyroid gland hormone hypofunction) Mean = 14.01
stdev = 2.21
26 IGE Immunoglobulin type E (indicating impaired/decreased humoral immunity) Mean = 135.91
stdev = 245.59
27 Output Vaccine response (0 = negative, less then fourfold increase in antibody titre)
(1 = positive, fourfold and more increase in antibody titre)
0 = 32.26%
1 = 67.74%
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left out of training, (3) 10 different results were obtained for each
model, (4) an average of 10 obtained results, i.e. average error
was computed [16]. The generalization ability in our study was
measured by the average error, and the model with the lowest
average error was selected as the best model.
The 10-fold CV procedure was performed on each of the three
NN models: MLP, RBFN and PNN, as well as on the LR model. The
size of the subsamples is presented in Table 2.
The purpose of the study was to design a computer-based neu-
ral network (NN) model that will enable successful prediction of
the outcome of inﬂuenza vaccine efﬁcacy based on data related
to inﬂuenza viruses and inﬂuenza vaccination, in combination with
historical medical data. The creation of the NN and LR models in
this study was based on the immune response to the inﬂuenzavirus strain B whose content in the vaccine was recently changed
(new inﬂuenza virus vaccine strain) and on which a poor antibody
response is expected [23].
3. Methods
3.1. Neural network methodology
Three NN algorithms were tested: MLP, radial basis and proba-
bilistic. The output layer of all three NN models consisted of one
neuron (valued as 1 for the positive response, and 0 for the nega-
tive response). One hidden layer was used in all NN models in
our experiments. With regard to the number of hidden units, the
method of pruning was used which eliminates weights which are
lower than the threshold (0.05 in our experiments) input and
Table 2
Sampling in the 10-fold cross-validation procedure.
Sample Total
Number of patients Proportion (%)
Train 80 90
Test 10 10
Total 90 100
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smaller and faster networks with equivalent performance. The ini-
tial number of hidden units was set to 15 in MLP networks, and to
one-half of the size of the training sample in RBFN and to the size
of the training sample in the PNN. Overtraining was avoided by a
split-sample process which alternatively trains and tests the net-
work (using a separate test sample) until the performance of the
network on the test sample does not improve for n number of iter-
ations. The maximum number of training epochs was set to 600.
The generalization ability of all three NN models was determined
by a 10-fold cross-validation procedure described in Section 2.
The level of output sensitivity to each input variable in NNmod-
els was computed by sensitivity analysis. Sensitivity analysis stud-
ies how the variation in the output of a mathematical model can be
apportioned to different sources of variation in the input of a mod-
el. It is a technique that systematically changes model parameters
to determine the effects of such changes [25]. The basic principle is
that experimenting with a wide range of values gives insight into
the behavior of a system in extreme situations, and can lead to
identiﬁcation of parameters whose speciﬁc value can signiﬁcantly
inﬂuence the behavior of the model.
There are various approaches to sensitivity analysis. We used a
common OAT (one-factor-at-a-time) approach which changes the
values of one input variable to seewhat effect it produces on the out-
put, while all other variables are ﬁxed to their central or baseline va-
lue [26]. The level of importance of each input variable is computed
by a sensitivity index,which represents the relative sensitivity of the
output to the changes of an input. Among the number of developed
sensitivity indices, we used the importance index which can be
interpreted to show the relative importance of an input variable to
the output. A higher value of importance indexmeans higher sensi-
tivity of the output to changes of that particular input.
3.2. Logistic regression methodology
The aim of LR modeling in this study was to estimate the risk of
reaction to inﬂuenza vaccine and to extract variables which are
found to be important in risk prediction. The LR model used the
same initial set of input variables as the NN model (see Table 1)
with the forward selection procedure (selection criteria was
p < 0.05). At the output, a binary variable was used with one cate-
gory representing a patient with a negative inﬂuenza vaccine out-
come (0) and the other representing a patient with a positive
inﬂuenza vaccine outcome (1). The SAS software was used to con-
duct the procedure, with standard overall ﬁt measures such as like-
lihood ratio and score, as well as c statistics which measure
discriminative power of logistic equation.
3.3. Evaluating model performance
The performance of the NN and LR models was measured by the
hit rate of negative vaccine outcome (i.e. the ‘‘negative hit rate” –
hit0), hit rate of positive vaccine outcome (i.e. the ‘‘positive hit rate”
– hit1), and the average hit rate (ave hit) computed by:
hit0 ¼ c0t0 ; hit1 ¼
c1
t1
; ave hit ¼ hit0 þ hit1
2
ð3Þwhere c0 is the number of patients accurately predicted to have
negative vaccine outcome (i.e. the number of true negatives), t0 is
the number of patients with actual (target) negative vaccine out-
come, c1 is the number of patients accurately predicted to have po-
sitive vaccine outcome (i.e. the number of true positives), and t1 is
the number of patients with actual positive vaccine outcome. The
above performance measures were computed on test samples for
all 10 NN and LR models. In order to test the generalization ability
of the models, the average hit rate of all ten samples was also com-
puted and used as the measure of model performance, as well as the
model selection criterion. The positive hit rate is equivalent to the
term of model sensitivity, while the negative rate is equivalent to
the model speciﬁcity, which is important when investigating the
ability of the model to accurately recognize positive and negative
outcomes. The computation of sensitivity and speciﬁcity also ex-
plains the proportion of false negatives or false positives that the
models produce. For this purpose, their sensitivity and speciﬁcity
ratios were computed in each of the 10 test samples used in the
10-fold cross-validation procedure, and type I and type II errors
were calculated. The sensitivity is computed according to:
sensitivity ¼ c1ðc1 þ d0Þ ð4Þ
where c1 is the number of true positives and d0 is the number of
false negatives [26]. The speciﬁcity is computed according to:
specificity ¼ c0ðc0 þ d1Þ ð5Þ
where c0 is the number of true negatives and d1 is the number of
false positives. The sensitivity is equivalent to the positive hit rate
hit0, while the speciﬁcity is equivalent to the negative hit rate hit1
(see Eq. (3)). The false positive rate (i.e. type I error) is computed
as a = 1  speciﬁcity, while the false negative rate (i.e. type II error)
is computed as b = 1  sensitivity. Comparison of false positive and
false negative rates explains the tendency of a model to misclassify
positive patients into the group of negatives, or negative patients
into the group of positive patients [26]. The model with a high sen-
sitivity could be used to screen for disease, since it has a tendency to
misclassify more negative patients into the group of positive
patients. The model with a high speciﬁcity could be used to conﬁrm
the test results, since it is more speciﬁc in recognizing the actual
positive patients. The ideal situation would be that both the sensi-
tivity and speciﬁcity of a model have high values [26].
4. Results
Among the three tested NN algorithms (MLP, RBFN and PNN),
the best performance with regard to the average hit rate was ob-
tained by the MLP algorithm. The results of the best NN model
and LR models of the 10-fold cross-validation procedure are pre-
sented in Table 3.
It can be seen from Table 3 that the MLP hit rates across 10 sam-
ples in the 10-fold CV procedure varied, with the average hit rate of
72.52%. Following the modeling strategy described in Section 3, the
best model is the model with the highest average hit rate out of the
10 samples. Therefore, the procedure showed that the NN model
was more successful than the LR model. In order to analyze the sta-
tistical signiﬁcance of the difference in the average hit results of
the two models, non-parametric Mann–Whitney test was con-
ducted since it is more appropriate in this case due to the small-
sample size [27]. The results of the test showed that the difference
between the average hit rates of the NN model and the LR model
was signiﬁcant at the level 10% (p = 0.0587).
Due to the fact that the difference in performance (i.e. the aver-
age hit rate) was statistically signiﬁcant, it can be concluded that
the NN model was more accurate in predicting vaccine outcome
Table 3
Neural network and logistic regression results of the 10-fold cross-validation procedure.
Test sample in CV
procedure
Results of NN model Results of LR model
Ave. hit
rate (%)
Positive (1) hit
rate (%)
Negative (0) hit
rate (%)
Ave. hit
rate (%)
Positive (1) hit
rate (%)
Negative (0) hit
rate (%)
LR model ﬁtting measures
1 50.00 33.33 66.67 83.33 100.00 66.67 Likelihood ratio: 22.72, p = 0.0009, Score:
18.56, p = 0.005, c = 0.808
2 50.00 100.00 0.00 52.50 80.00 25.00 Likelihood ratio: 18.33, p = 0.0004, Score:
15.67, p = 0.0013, c = 0.782
3 28.57 57.14 0.00 42.50 60.00 25.00 Likelihood ratio: 36.72, p < 0.0001, Score:
28.93, p = 0.0001, c = 0.876
4 83.33 66.67 100.00 35.71 71.43 0.00 Likelihood ratio: 21.20, p = 0.0003, Score:
17.40, p = 0.0016, c = 0.797
5 83.33 100.00 66.67 65.00 80.00 50.00 Likelihood ratio: 36.83, p < .0001, Score:
28.94, p = 0.0001, c = 0.872
6 83.33 66.67 100.00 53.57 57.14 50.00 Likelihood ratio: 21.44, p < .0001, Score:
18.76, p = 0.0003, c = 0.791
7 91.67 100.00 83.33 60.71 71.43 50.00 Likelihood ratio: 19.34, p = 0.0002, Score:
16.56, p = 0.0009,c = 0.795
8 75.00 83.33 66.67 66.67 66.67 66.67 Likelihood ratio: 23.27, p = 0.0003, Score:
20.11, p = 0.0012, c = 0.799
9 90.00 100.00 80.00 58.33 50.00 66.67 Likelihood ratio: 28.31, p = 0.0002, Score:
22.42, p = 0.0021, c = 0.843
10 90.00 80.00 100.00 33.33 66.67 0.00 Likelihood ratio: 27.01, p = 0.0001,Score:
21.80, p = 0.0013,0.842
Ave. hit rate across
10 samples
72.52 78.71 66.33 55.17 70.33 40.00
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NN model is observed separately, it can be seen that the average
hit rate was higher for the positive group of patients (78.71%) than
for the negative group of patients (66.33%) indicating that this
algorithm recognizes positive patients more easily.
Table 4 presents the average sensitivity and speciﬁcity, as well
as type I and type II errors of the NN model, while these ratios ob-
tained by the LR model are presented in Table 5. It can be seen from
Table 4 that the speciﬁcity of the NN model is 0.79, while its sen-
sitivity is 0.66. The false positive rate (i.e. type I error) of the NN
model is 0.21, while the false negative rate (i.e. type II error) is
0.24. It reveals that the NN model is more sensitive than speciﬁc,
tending to misclassify more patients who actually had negative
vaccine outcome into the category of positive vaccine outcome.
However, the difference between type I and type II errors is small,
implying that the NN model is able to balance between sensitivity
and speciﬁcity.
Although the LR model is also more sensitive than speciﬁc (see
Table 5), both its sensitivity and speciﬁcity ratios are smaller than
the same ratios of the NN model. The LR model’s false positive rate
(0.30) is twice as small as its false negative rate (0.60).
In order to further investigate the importance of each input var-
iable to the output, sensitivity analysis was performed on each NNTable 4
The average sensitivity and speciﬁcity of the NN model.
Vaccine outcome predicted by the NN models Actual vaccine outcome
1 (positive) 0 (negative)
1 (positive) 0.79 0.24
0 (negative) 0.21 0.66
Table 5
The average sensitivity and speciﬁcity of the LR model.
Vaccine outcome predicted by the NN models Actual vaccine outcome
1 (positive) 0 (negative)
1 (positive) 0.70 0.60
0 (negative) 0.30 0.40model in the 10-fold cross-validation procedure, and the average
sensitivity ratio of the inﬂuenza vaccine outcome to input variables
is presented in Fig. 1.
The analysis shows that the VACC is the variable with the high-
est inﬂuence on the vaccine outcome, closely followed by the HPG.
The average sensitivity ratio is also high for variables PSYCH, BETA,
HPA, EO, VITB12 and CRCLEA (sensitivity ratio higher than 1.1),
while the ratio of other input variables is around 1.0. The variables
with the lowest ratios (less than 1.0) are: AGE, H1N1_1, LY and
HOMCYS.
In the process of LR modeling, a forward selection procedure
was used to select input variables important for the model. By
using such selection criteria, the LR extracted a total set of nine in-
put variables: EO, VITB12, GLU, AGE, VACC, HPG, BETA, LY and IGE.
Although the procedure of selecting input variables differs from
the one used in NN modeling, some of the highly ranked variables
identiﬁed by the NNs were also extracted by the LR models. If the
rank of input variables is compared across NN and LRmodels, it can
be seen that almost all variables extracted by the LR also had very
high importance for the NNs (such as VACC, HPG, EO, VITB12, BETA,
GLU), while some of the variables (such as AGE, IGE, and LY) were
found to be signiﬁcant for the LR model, although not very impor-
tant for the NN model.5. Discussion
The results clearly indicate that both types of data, those related
to previous inﬂuenza viruses exposure and those describing the
health status of examinees, inﬂuence outcome values of performed
predictive models and could be used as efﬁcient predictors of the
inﬂuenza vaccine efﬁcacy (Fig. 1). The reason for the low inﬂuence
of the variable AGE in the NN models could be found in the sample
structure, since most of the patients in the observed sample were
elderly (mean age 67.67 years) (Table 1, Fig. 1). Furthermore, the
variable AGE can hardly be separated from the factors related to
previous antigenic exposure, and from factors related to chronic
health disorders, both known to be age-dependent.
With regard to the inﬂuenza vaccine component, the content of
which was recently changed (new inﬂuenza virus strain), such as
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Fig. 1. Sensitivity ratios of the output variable towards the input variables.
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could be the number of previous vaccinations (variable VACC)
(Fig. 1). In this connection, we analyzed the postvaccination anti-
body titres in relation to the number of previous vaccinations for
all three inﬂuenza virus strains contained in the vaccine prepara-
tion used in the study (A/H1N1, A/H3N2 and B/Hong Kong). Indeed,
a statistically signiﬁcant decrease was only found for the compo-
nent B/Hong Kong and only for individuals frequently vaccinated
(previously vaccinated four or more times) (The results are not pre-
sented in the study). This may be a consequence of the negative
impact of heterologous immune reaction (to inﬂuenza B virus
strains from vaccine preparations used for vaccination in the re-
cent past, before the last vaccine change) [23].
The results also show that for building a model of prediction the
health status of examinees must be described with regard to many
aspects (Fig. 1). Hematological and biochemical laboratory tests are
preferable, in comparison to clinical diagnoses of diseases (only
one diagnosis, that of neuropsychiatric disease, was selected as
being relevant for prediction of low antibody response to inﬂuenza
vaccination) (Table 3 and Fig. 1).
Some of the relevant variables, those with the highest inﬂuence
on the vaccine outcome, are likely to indicate chronic clinical con-
ditions which, in elderly people, could affect the antibody immune
response. These variables are: (1) PSYCH, indicating neuropsychi-
atric diseases, (2) HPA (and HPG), indicating Helicobacter pylori po-
sitive chronic gastritis, and (3) CRLEA, indicating chronic renal
impairment. Other variables, shown in this study to be necessary
for the modeling, may represent common intermediate mecha-
nisms, associated with these main clinical conditions (Fig. 1).
In accordance with these explanations, low inﬂuenza vaccina-
tion antibody response was found in the elderly with dementia/
depression [28]. Evidence suggests that, in elderly people, both dis-
orders, anxiety/depression and neurodegenerative/cognitive
impairments, are closely related and frequently occur together
[29]. Mechanisms such as neuroendocrine disorders, including also
hyperprolactinemia and thyroid gland hormone hypofunction (in
our results indicated by the variables PRL, FT3, FT4 and TSH),
may link these disorders with impaired immune response to inﬂu-
enza vaccination [30–32]. Another proposed mechanism may be
chronic activation of immunocomponent cells, during the course
of neurodegenerative processes [33]. This can lead to a deﬁciency
of vitamin B12 and, in turn, to impaired immune reaction, because
this vitamin is necessary for proliferation of immunocompetent
cells [34,35]. These assumptions, in our results, are likely to be rep-
resented by the variables: VITB12, MCV, MO and LY (Table 1,
Fig. 1). The above explanation, based on existing knowledge on
the issue, may be the reason for differences in variable selection,
between the two used methods of prediction: the LR and the NN.
Namely, because of the mutual interdependence between variablesVITB12 and LY, they could gain different statistical power in the
two models, based on the different performance due to linearity
and dependence among the data.
Chronic gastritis is a frequent disorder in older people. In the
majority of cases, it is caused by H. pylori infection. This disorder
can be described as chronic inﬂammatory reaction in the gastric
submucosa. Chronic inﬂammation and mechanisms such as in-
creased oxidative stress and cytokine production may contribute
to enhanced lymphocyte apoptosis and lymphopenia and, conse-
quently, to impaired immune reaction [36]. In addition, because
of intensive activation of B-lymphocytes in gastric submucosa,
the disorder may lead to impairment of the speciﬁc humoral im-
mune response [37]. In our results all these mechanisms, linking
chronic gastritis with insufﬁcient antibody production to inﬂuenza
vaccination, are likely to be implicated by variables such as: BETA,
EO, ALB, MO, IGE, GAMA and LY (Table 1 and Fig. 1). Close func-
tional association between these variables may be the reason for
complementariness among some of them, such as, e.g., the paired
variables EO and IGE, indicating the same pathogenetic disorder
– impaired humoral immunity. This may also provide a reasonable
explanation for differences in selection of these variables in two
different models of prediction: the LR and the NN.
Some other mechanisms can be proposed, linking chronic gas-
tritis with low antibody response to inﬂuenza vaccination. Such
mechanisms include vitamin B12 deﬁciency, probably due to mal-
absorption, and thyroid gland hormone hypofunction, due to evi-
dence showing that chronic gastritis and chronic autoimmune
thyroiditis, both common aging diseases, usually appear in co-
morbidity [38,39].
In general, B-vitamin deﬁciency and mild hyperhomocystein-
emia, closely related metabolic disorders, may be markers of im-
paired cell cycling [40]. This may have the greatest negative
impact on the function of cells with a high cell turn-over, such as
immunocomponent cells [35,41].
Chronic renal impairment, a clinical condition in our results
negatively inﬂuencing antibody response to inﬂuenza vaccination,
has frequently been found to be associated with numerous disor-
ders. Many of them are intermediate mechanisms, already men-
tioned above, including: inﬂammation, lymphopenia, increased
mononuclear leukocyte activity, B-vitamin deﬁciency, hyperhomo-
cysteinemia, as well as multiple neuroendocrine disorders [42–46].
Low-grade inﬂammation, common in patients with decreased re-
nal function, is also associated with strong protein malnutrition,
which in our results is most likely indicated by variables ALB and
SKINFOLD (Table 1 and Fig. 1). Inﬂammation and protein malnutri-
tion are mechanisms which both may affect the immune system
function [47]. Moreover, metabolic disorders, including hyperhom-
ocysteinemia and impaired glucose metabolism, are usually associ-
ated with inﬂammation/malnutrition, forming a unique syndrome
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able GLU, indicating fasting blood glucose concentration (Table 1
and Fig. 1).
Hence, for inﬂuenza vaccine strains which are frequently chan-
ged (such as the B/Hong Kong vaccine strain), the poorest antibody
response after vaccination can be expected in individuals previ-
ously vaccinated several times and who, in addition, are burdened
by health disorders, with great impact on the immune reaction.6. Conclusion
The aim of the study was to design an intelligent computer-
based neural network model that will enable successful prediction
of the outcome of inﬂuenza vaccine efﬁcacy. The model is based on
the results of vaccination by the inﬂuenza vaccine strain, the con-
tent of which was recently changed (in this case the B/Hong Kong
vaccine strain) and on which, therefore, a poor antibody response
was expected. The results were compared with a standard logistic
regression approach. The input space consisted of 26 input vari-
ables, comprising both variables related to previous inﬂuenza virus
exposure and previous vaccinations and variables describing many
aspects of the health status of a group of high-risk older patients
vaccinated against inﬂuenza.
Multilayer perceptron, radial-basis function, probabilistic neural
network and logistic regressionwere used to predict the outcome of
inﬂuenza vaccination, based on a set of previously selected input
variables. Due to the small-sample size, it was necessary to perform
a 10-fold cross-validation procedure in order to estimate the gener-
alization ability of the model. The procedure showed that the mul-
tilayer perceptron algorithm had the highest average performance
obtained on 10 samples, and therefore can be proposed as the mod-
el that generalizes better. The sensitivity and speciﬁcity ratios of the
NN model were also higher than those ratios of the LR model. The
neural network model was also able to balance between the false
positive and false negative hit rates, showing that it was able to
determine important features necessary to correctly classify
patients with negative vaccine outcome and those with positive
vaccine outcome.
The sensitivity analysis showed that the following predictor
variables have the greatest importance for the output: VACC (the
number of previous vaccinations), HPG (H. pylori speciﬁc antibodies
type IgG), PSYCH (neuropsychiatric disease), BETA (beta-globulins
in serum proteins electrophoresis), HPA (H. pylori speciﬁc antibod-
ies type IgA), EO (eosinophils % in White Blood Cell differential),
VITB12 (vitamin B12), and CRCLEA (creatinine clearance). Although
the logistic regression approach extracted a more narrow set of
predictors, it produced a signiﬁcantly lower average hit rate com-
pared to the neural network approach, implying that the multi-
layer structure of neural networks is more capable of
understanding the interconnections among input variables and
the output in order to successfully predict the vaccine output. Re-
sults obtained by both methods clearly indicate that the health sta-
tus of the examined patients, for the purpose of prediction, must be
determined by many aspects, and by a sufﬁciently large set of vari-
ables. This is due to the nature of chronic health disorders, charac-
terized by many factors, each having only small predictive power.
Since this is a preliminary study, improvement in model perfor-
mance can be expected by increasing the number of patients in-
cluded in the dataset, and by using other intelligent methods,
such as genetic algorithms, support vector machines, and other
classiﬁers which could combine with neural networks in order to
build a more successful model. The potential of the methodology
in this ﬁeld is evident, and beneﬁt from this research in primary
health care can be anticipated, as well as in more global strategic
planning of inﬂuenza vaccination.References
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